MH vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

MH

31.9
AI Score
VS
UTI Wins

UTI

39.4
AI Score

Investment Advisor Scores

MH

32score
Recommendation
SELL

UTI

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric MH UTI Winner
Forward P/E 9.4967 28.4091 MH
PEG Ratio 0 1.8924 Tie
Revenue Growth 2.6% 7.2% UTI
Earnings Growth 9860.2% -78.9% MH
Tradestie Score 31.9/100 39.4/100 UTI
Profit Margin 4.4% 3.9% MH
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

MH 1M: +6.2% · 3M: -0.3% UTI 1M: -20.8% · 3M: -50.2%

Current Technical Phase

MH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $12.32

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 27

RSI (14): 26.9 · Price: $20.31

Fundamentals Snapshot

Metric MH UTI
Market Cap
Forward P/E 7.0 27.6
Trailing P/E 25.2 34.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.6%
Operating Margin 0.2% 0.0%
EPS 0.48 0.59
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.